Adverse Events

Pravastatin, Rosiglitazone, and Growth Hormone Fail as Treatments for HIV-related Lipoatrophy   10/10/06

Lower Rate of Abacavir Hypersensitivity Reaction among Black Patients   10/06/06

Fixed-dose Abacavir/3TC Administered Once-daily Compared with Separate Components Twice-daily: The ALOHA Study   10/06/06

Trizivir versus Unboosted Atazanavir/AZT/3TC: The ACTION Study   10/03/06

NRTI-sparing Atazanavir/Efavirenz Regimens Suppress HIV but Raise Lipids   10/03/06

Liver Toxicity Associated with Ritonavir-boosted Tipranavir   10/03/06

Nevirapine Liver Toxicity Not Linked to Higher CD4 Counts in 2 Studies   10/03/06











Google_______________



 

 

 

 



 

 

 

 

 


Conference
Main Page